Specifically, a prior history of low-grade NET, aberrant ATRX, or DAXX staining suggests a G3 NET; aberrant expressions of p53, a global loss of Rb or SMAD4, or coexisting adenocarcinoma are supportive of a NEC diagnosis [63]. This evidence concerns the gene TP53 and neuroendocrine carcinoma.